Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing - Abasic lesions as a tool to dissect enzyme mechanism

被引:35
作者
Kingma, PS
Osheroff, N
机构
[1] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med Oncol, Sch Med, Nashville, TN 37232 USA
关键词
D O I
10.1074/jbc.273.29.17999
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of topoisomerase II with its DNA cleavage site is critical to the physiological functions of the enzyme. Despite this importance, the specific enzyme-DNA interactions that drive topoisomerase II-mediated DNA cleavage and religation are poorly understood. Therefore, to dissect interactions between the enzyme and its cleavage site, abasic DNA lesions were incorporated into a bilaterally symmetrical and identical cleavage site, Results indicate that topoisomerase II has unique interactions with each position of the 4-base overhang generated by enzyme-mediated DNA cleavage. Lesions located 2 bases 3' to the point of scission stimulated cleavage the most, whereas those 3 bases from the point of scission stimulated cleavage the least. Moreover, an additive and in some cases synergistic cleavage enhancement was observed in oligonucleotides that contained multiple DNA lesions, with levels reaching >60-fold higher than the wild-type substrate. Finally, topoisomerase II efficiently cleaved and religated a DNA substrate in which apyrimidinic sites were simultaneously incorporated at every position on one strand of the 4-base overhang. Therefore, unlike classical DNA ligases in which base pairing is the driving force behind closure of the DNA break, it appears that for topoisomerase II, the enzyme is responsible for the spatial orientation of the DNA termini for ligation.
引用
收藏
页码:17999 / 18002
页数:4
相关论文
共 30 条
[1]   Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity [J].
Bigioni, M ;
Zunino, F ;
Tinelli, S ;
Austin, CA ;
Willmore, E ;
Capranico, G .
BIOCHEMISTRY, 1996, 35 (01) :153-159
[2]   DNA TOPOISOMERASE-TRAPPING ANTITUMOR DRUGS [J].
CAPRANICO, G ;
ZUNINO, F .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) :2055-2060
[3]   LOCAL SEQUENCE REQUIREMENTS FOR DNA CLEAVAGE BY MAMMALIAN TOPOISOMERASE-II IN THE PRESENCE OF DOXORUBICIN [J].
CAPRANICO, G ;
KOHN, KW ;
POMMIER, Y .
NUCLEIC ACIDS RESEARCH, 1990, 18 (22) :6611-6619
[4]   DNA TOPOISOMERASES - ESSENTIAL ENZYMES AND LETHAL TARGETS [J].
CHEN, AY ;
LIU, LF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :191-218
[5]   WHEN GOOD ENZYMES GO BAD - CONVERSION OF TOPOISOMERASE-II TO A CELLULAR TOXIN BY ANTINEOPLASTIC DRUGS [J].
CORBETT, AH ;
OSHEROFF, N .
CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (05) :585-597
[6]  
Cozzarelli Nicholas R., 1990, DNA TOPOLOGY ITS BIO
[7]  
FELIX CA, 1995, CANCER RES, V55, P4287
[8]   MUTATIONAL ANALYSIS OF A TYPE-II TOPOISOMERASE CLEAVAGE SITE - DISTINCT REQUIREMENTS FOR ENZYME AND INHIBITORS [J].
FREUDENREICH, CH ;
KREUZER, KN .
EMBO JOURNAL, 1993, 12 (05) :2085-2097
[9]   LOCALIZATION OF AN AMINOACRIDINE ANTITUMOR AGENT IN A TYPE-II TOPOISOMERASE DNA COMPLEX [J].
FREUDENREICH, CH ;
KREUZER, KN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11007-11011
[10]   TOPOISOMERASE POISONS - HARNESSING THE DARK SIDE OF ENZYME MECHANISM [J].
FROELICHAMMON, SJ ;
OSHEROFF, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21429-21432